Abstract:Studies in continuously cultured cells have established that familial Alzheimer's disease (FAD) mutant presenilin 1 (PS1) delays exit of the amyloid precursor protein (APP) from the trans-Golgi network (TGN). Here we report the first description of PS1-regulated APP trafficking in cerebral neurons in culture and in vivo. Using neurons from transgenic mice or a cell-free APP transport vesicle biogenesis system derived from the TGN of those neurons, we demonstrated that knocking-in an FAD-associated mutant PS1 transgene was associated with delayed kinetics of APP arrival at the cell surface. Apparently, this delay was at least partially attributable to impaired exit of APP from the TGN, which was documented in the cell-free APP transport vesicle biogenesis assay. To extend the study to APP and carboxyl terminal fragment (CTF) trafficking to cerebral neurons in vivo, we performed subcellular fractionation of brains from APP transgenic mice, some of which carried a second transgene encoding an FAD-associated mutant form of PS1. The presence of the FAD mutant PS1 was associated with a slight shift in the subcellular localization of both holoAPP and APP CTFs toward iodixanol density gradient fractions that were enriched in a marker for the TGN. In a parallel set of experiments, we used an APP : furin chimeric protein strategy to test the effect of artificially forcing TGN concentration of an APP : furin chimera that could be a substrate for beta- and gamma-cleavage. This chimeric substrate generated excess Abeta42 when compared with wildtype APP. These data indicate that the presence of an FAD-associated mutant human PS1 transgene is associated with redistribution of the APP and APP CTFs in brain neurons toward TGN-enriched fractions. The chimera experiment suggests that TGN-enrichment of a beta-/gamma-secretase substrate may play an integral role in the action of mutant PS1 to elevate brain levels of Abeta42.

Ubiquilin 1 modulates amyloid precursor protein trafficking and Abeta secretion

GM1 up-regulates Ubiquilin 1 expression in human neuroblastoma cells and rat cortical neurons.

UBB+1 reduces amyloid-β cytotoxicity by activation of autophagy in yeast

Intracellular trafficking of presenilin 1 is regulated by beta-amyloid precursor protein and phospholipase D1.

Intracellular Trafficking of Presenilin 1 Is Regulated by β-Amyloid Precursor Protein and Phospholipase D1

Ubiquitin Hydrolase Uch-L1 Rescues Β-Amyloid-induced Decreases in Synaptic Function and Contextual Memory

Amyotrophic Lateral Sclerosis (ALS) Linked Mutation in Ubiquilin 2 Affects Stress Granule Assembly Via TIA-1.

Abeta-induced presynaptic release of UBC9 through extracellular vesicles involves SNAP23

Effects of U1 Small Nuclear Ribonucleoprotein Inhibition on the Expression of Genes Involved in Alzheimers Disease

Alzheimer's presenilin 1 modulates sorting of APP and its carboxyl-terminal fragments in cerebral neurons in vivo.

Interaction Between Amyloid Precursor Protein and Nogo Receptors Regulates Amyloid Deposition

U1 small nuclear RNA overexpression implicates autophagic-lysosomal system associated with AD.

A Preliminary Study: PS1 Increases U1 Snrna Expression Associated with AD

Relationship Between Amyloid-Beta and the Ubiquitin–proteasome System in Alzheimer’s Disease

Mutations of beta-amyloid precursor protein alter the consequence of Alzheimer's disease pathogenesis.

Increased neuronal expression of the early endosomal adaptor APPL1 leads to endosomal and synaptic dysfunction with cholinergic neurodegeneration

Amyolid Precursor Protein Mediates Presynaptic Localization and Activity of the High-Affinity Choline Transporter

SNX15 Regulates Cell Surface Recycling of APP and Aβ Generation

RABGAP1 acts as a sensor to facilitate sorting and processing of amyloid precursor protein

App Regulates Ngf Receptor Trafficking And Ngf-Mediated Neuronal Differentiation And Survival

Suppressing UBE2N ameliorates Alzheimer's disease pathology through the clearance of amyloid beta